Enrolling by invitationPhase 2NCT04240821
Theophylline for Treatment of Pseudohypoparathyroidism
Studying Pseudohypoparathyroidism
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Ashley Shoemaker
- Principal Investigator
- Ashley Shoemaker, MDVanderbilt University Medical Center
- Intervention
- Theophylline ER(drug)
- Enrollment
- 34 enrolled
- Eligibility
- 2-99 years · All sexes
- Timeline
- 2020 – 2026
Study locations (1)
- Vanderbilt University Medical Center, Nashville, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04240821 on ClinicalTrials.gov